The Idiopathic Pulmonary Fibrosis (IPF) Treatment Market has been witnessing remarkable growth over the past decade, driven by rising disease awareness, advancements in diagnostic tools, and the introduction of novel therapeutic options. Idiopathic pulmonary fibrosis is a chronic, progressive lung disorder characterized by scarring (fibrosis) of lung tissue, leading to respiratory...